Browsing All posts tagged under »EU«

Further discussion of the EU Clinical Trials Regulation in Europe

September 5, 2013 by


We have supported a briefing on the EU Clinical Trials Regulation ahead of trialogue negotiations between MEPS, the Council and Commission.

Clinical Trials – proportionate regulation is necessary but not sufficient

May 2, 2013 by


Last week we gave evidence to the Science and Technology Committee on barriers facing clinical trials and possible solutions to increase their effectiveness.

What do we want to see in the new Clinical Trials Regulation?

November 23, 2012 by


We have supported a joint statement welcoming proposed revisions to the law governing clinical trials across the EU and highlighting where we think they could be improved.

Rare diseases and orphan drugs: making research viable

September 11, 2012 by


How can you encourage private firms to invest in R&D for drugs that have a small market population?

EU publishes proposal to improve regulation of clinical trials

July 18, 2012 by


The European Commission has published a new Regulation to update the EU Clinical Trials Directive.

New report on improving access to patient data

June 25, 2012 by


The British Heart Foundation's Joseph Clift on the report published today outlining the value of patient data for research and how we should approach some of the challenges involved in using this data.

Research funders urge EU to support stem cell research

June 15, 2012 by


Research funders from across Europe have written to the EU urging all members to support stem cell research.